Merrimack Pharmaceuticals Story

Merrimack Pharmaceuticals Inc -- USA Stock  

USD 10.38  0.23  2.27%

Macroaxis does not monitor all media channels or aggregates social signals for Merrimack Pharmaceuticals. But even though we do not provide professional-grade financial sentiment analysis on Merrimack Pharmaceuticals, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Merrimack Pharmaceuticals. Please see also Merrimack Pharmaceuticals Hype Analysis, Merrimack Pharmaceuticals Correlation and Merrimack Pharmaceuticals Performance
Acquisition by John Mendelsohn of 7500 shares of Merrimack Pharmaceuticals subject to Rule 16b-3
Filed transaction by Merrimack Pharmaceuticals director. Grant, award or other acquisition pursuant to Rule 16b-3

Merrimack Pharmaceuticals Inc insider trading alert for grant of stock option (right to buy) by John Mendelsohn, the corporate stakeholder, on December 7, 2017. This event was filed by Merrimack Pharmaceuticals with SEC on 2017-09-15. Statement of changes in beneficial ownership - SEC Form 4

Cash Floor Correlation

Click cells to compare fundamentals   View All Correlations

Story Momentum

This media report from MacroaxisInsider distributed on December 7, 2017 was a factor to the next trading day price appreciation.The trading delta at closing time against the next closing price was 0.95% . The trading delta at closing time when the story was published against the current closing price is 0.67% .

Similar stores for Merrimack Pharmaceuticals

2 days ago at http://ledgergazette.com 
Northern Trust Corp Has 1.80 Million Holdings in Merrimack Pharmaceuticals ...
news
Merrimack Pharmaceuticals logo Northern Trust Corp grew its stake in Merrimack Pharmaceuticals, Inc. by 2.0 percent in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission.
few days ago at http://simplywall.st 
Merrimack Pharmaceuticals Inc Delivered A Better ROE Than The Industry, Heres Why
news
Simply Wall St33.00 Million in Sales Expected for Merrimack Pharmaceuticals, Inc. This Quarter StockNewsTimesSanta Barbara Asset Management Boosted Sap Se Stake Merrimack Pharmaceuticals, Inc. Covered By ... HuronReportFull coverage

Did you try this?

Run Idea Breakdown Now
   

Idea Breakdown

Analyze constituents of all Macroaxis ideas. Macroaixs investment ideas are predefined, sector-focused investing themes
Hide  View All  NextLaunch Idea Breakdown

Operating Margin

Operating Margin Comparative Analysis
  Operating Margin 
      Merrimack Pharmaceuticals Comparables 
Merrimack Pharmaceuticals is currently under evaluation in operating margin category among related companies. Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.